RCP Therapeutics Ltd acquires the IP and assets of Telemolecular Corporation

New operational headquarters situated in London, UK

07-Nov-2008 - United Kingdom

RCP Therapeutics, a biopharmaceuticals company specialising in converging nanotechnology and regenerative medical markets, announced that it has exclusively licensed technologies from Telemolecular Corporation (USA). The Company’s portfolio of intellectual property is strategically focused on the regenerative, preventative and curative elements of age related disease states.

RCP Therapeutics has identified a series of product candidates and has pilot launched its lead product candidate, Bimene, a novel cosmeceutical topical product, utilising its nano particle delivery platform acquired via licenses from universities and US based research institutions.

New management, appointed to run Telomolecular Corporation in May 2008, set in motion a business strategy culminating in the formation of RCP Therapeutics. Operationally, the Company will retain its research laboratory in Sacramento, securing the facilities status as RCP Therapeutics’ primary research and development site. Furthermore, the Company’s plans to expand the Californian operation and increase the number of scientists and staff employed at the site. Commercialisation of RCP Therapeutics’ cosmeceutical products in the US will be co-ordinated from the same location.

Other news from the department business & finance

These products might interest you

Eclipse

Eclipse by Wyatt Technology

FFF-MALS system for separation and characterization of macromolecules and nanoparticles

The latest and most innovative FFF system designed for highest usability, robustness and data quality

DynaPro Plate Reader III

DynaPro Plate Reader III by Wyatt Technology

Screening of biopharmaceuticals and proteins with high-throughput dynamic light scattering (DLS)

Efficiently characterize your sample quality and stability from lead discovery to quality control

particle analyzers
Loading...

Most read news

More news from our other portals

So close that even
molecules turn red...